Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions

Douglas G. Adler, MD

Question 4: An 81-Year-Old Man Is Found To Have Unresectable Esophageal Cancer And Malignant Dysphagia. Should He Have A Stent? A Nasogastric Feeding Tube? A Percutaneous Endoscopic Gastrostomy Tube? (continued)

Katarina B. Greer, MD, MS; Ashley L. Faulx, MD, FASGE

Five-year survival of patients with esophageal cancer remains poor and generally does not exceed 20%. More than 50% of patients with esophageal cancer present with meta-static disease. A recent Cochrane Review based on 2 randomized controlled trials did not demonstrate any survival advantage for chemotherapy versus best supportive care in metastatic esophageal cancer.1 The management of malignant dysphagia is thus an important goal of palliative therapy. Treatment options for dysphagia include endoscopic stenting, feeding tube placement, radiation therapy, brachytherapy, or laser treatment…